BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31808361)

  • 1. Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.
    Chen YZ; Zuo D; Ren HL; Fan SJ; Ying G
    Technol Cancer Res Treat; 2019; 18():1533033819892260. PubMed ID: 31808361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of prognostic value of
    Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
    [No Abstract]   [Full Text] [Related]  

  • 4. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
    Zhu Y; Liu Y; Zhang C; Chu J; Wu Y; Li Y; Liu J; Li Q; Li S; Shi Q; Jin L; Zhao J; Yin D; Efroni S; Su F; Yao H; Song E; Liu Q
    Nat Commun; 2018 Apr; 9(1):1595. PubMed ID: 29686231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
    Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BARD1: an independent predictor of survival in non-small cell lung cancer.
    Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
    Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
    Sabatier R; Adélaïde J; Finetti P; Ferrari A; Huiart L; Sobol H; Chaffanet M; Birnbaum D; Bertucci F
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1143-51. PubMed ID: 20842729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families.
    De Brakeleer S; De Grève J; Loris R; Janin N; Lissens W; Sermijn E; Teugels E
    Hum Mutat; 2010 Mar; 31(3):E1175-85. PubMed ID: 20077502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
    Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients.
    Albarakati N; Al-Ghamdi H; Al-Sowayan B; Alshareeda A
    Sci Rep; 2023 Jul; 13(1):11738. PubMed ID: 37474724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.
    Lombardi G; Falaschi E; Di Cristofano C; Naccarato AG; Sensi E; Aretini P; Roncella M; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2007 Sep; 46(9):791-5. PubMed ID: 17497650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
    Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
    Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
    Liao Y; Yuan S; Chen X; Zhu P; Li J; Qin L; Liao W
    Sci Rep; 2017 Aug; 7(1):7649. PubMed ID: 28794477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH).
    Coté D; Eustace A; Toomey S; Cremona M; Milewska M; Furney S; Carr A; Fay J; Kay E; Kennedy S; Crown J; Hennessy B; Madden S
    PLoS One; 2018; 13(8):e0200996. PubMed ID: 30071039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
    Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BARD1 expression predicts outcome in colon cancer.
    Sporn JC; Hothorn T; Jung B
    Clin Cancer Res; 2011 Aug; 17(16):5451-62. PubMed ID: 21693656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.